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Background: Dogs with chronic inflammation, including those with heartworm being managed with macrocyclic
lactones and doxycycline (slow kill, SK), may develop immune complexes that block detection of Dirofilaria immitis
antigen on commercial tests.
Methods: To determine if SK could result in development of false-negative antigen tests, we collected serum samples
from dogs that had been diagnosed with heartworm by antigen detection, with or without confirmation by detection
of D. immitis microfilariae, placed on monthly macrocyclic lactones and doxycycline, and that later tested
negative on an antigen test, and then tested them for antigen of D. immitis before and after treatment to disrupt
immune complexes.
Results: Serum samples from a total of 15 dogs managed with SK were negative for antigen prior to heating on
commercial assay (DiroCHEK®, Zoetis) by colorimetric detection and spectrophotometry, but after heat treatment, 8/15
(53.3%) samples converted to positive. Review of the medical records of each dog indicated that, after the heartworm
diagnosis, only 7/15 (46.7%) dogs appeared to receive preventive monthly as prescribed, including 3 dogs that had
detectable antigen after heating the sample and 4 dogs that did not have detectable antigen after heating. Whole
blood was available from 9 dogs; microfilariae of D. immitis were detected in 1 sample.
Conclusions: These data suggest that immune complex formation in dogs infected with heartworm and managed
with SK can induce false negative antigen test results, misleading veterinarians and owners about the efficacy of this
approach. Moreover, compliance with preventive administration appears poor, even after a heartworm diagnosis. The
presence of persistent microfilaremia in at least one dog has implications for resistance selection.
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Slow kill (SK) is defined as the use of monthly macro-
cyclic lactone heartworm preventives, with or without
doxycycline, in lieu of melarsomine dihydrochloride
(Immiticide®, Merial) in dogs infected with adult Dirofi-
laria immitis [1]. Historically, veterinarians have used
SK to manage adult heartworm infections for a variety
of reasons, including when the approved adulticide is
not available, when the cost of adulticide treatment is
rejected by a dog owner, or when the medical risk of* Correspondence: susan.little@okstate.edu
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unless otherwise stated.adulticide therapy is thought to be too great. The prac-
tice of SK is explicitly discouraged within the guidelines
of both the American Heartworm Society (AHS) and the
Companion Animal Parasite Council (CAPC) [1,2]. The
European Scientific Counsel Companion Animal Para-
sites (ESCCAP) also explicitly does not recommend the
use of SK-like protocols [3].
Several reasons to avoid SK have been described, in-
cluding compliance failure and selection for resistance
[4]. The adult worms, which may be > 30 cm in length,
reside in the pulmonary arteries and cause severe in-
flammation, truncation of pulmonary vessels, thickening
of the arterial parenchyma, pulmonary hypertension andhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ticide, melarsomine dihydrochloride, is an effective
method for elimination of adult heartworms [10], while
SK methods of continuous monthly use of preventive
doses of macrocyclic lactones, with or without the addition
of doxycycline, result in worm death and elimination over
a lengthy and somewhat unpredictable period of time
[11,12]. Efficacy of SK is poor (56.3%) against 8-month-old
worms when monthly low-dose ivermectin is administered
for 16 consecutive months [11] but improves (94.9%) when
administered consistently for 29 consecutive months [12].
However, SK allows worms to continue to reside within
the pulmonary arteries, prolonging the inflammatory
process and allowing further disease progression [4].
Indeed, heartworm-infected dogs administered SK for
a one-year period developed radiographic signs of heart-
worm disease and severe pulmonary pathology with mul-
tiple pathologic changes including enlarged pulmonary
arteries, villous proliferation characteristic of heartworm
infection, alveolar disease, interstitial lung disease, and
parenchymal fibrosis [4].
In clinical practice and in clinical research projects,
veterinarians may use antigen testing as a proxy for SK
efficacy [13,14]. The relationship between antigen status,
microfilaremia, and the presence of adult worms in dogs
managed with SK has not been well defined. Interestingly,
in the original publication describing the prolonged death
of adult heartworms during monthly administration of
preventive, antigen levels decreased during administration
of ivermectin to heartworm-infected dogs even though
worms survived, suggesting the process of SK interferes
with either antigen production by D. immitis or antigen
detection by commercial tests [11].
All currently available heartworm preventives con-
tain macrocyclic lactones as the active ingredient against
D. immitis [15]. Recently, D. immitis resistant to macro-
cyclic lactone preventives have been described in North
America [16-18]. Repeated administration of preventives
to dogs infected with adult D. immitis may increase the
risk of resistance to macrocyclic lactones by increasing se-
lective pressure, placing all dogs, including uninfected
dogs maintained on preventives, at higher risk of infection
[15]. Although experimental data document that SK
methods require more than 1–2 years to eliminate adult
heartworms [11,12], some veterinarians have reported
dogs converting from D. immitis antigen positive to anti-
gen negative status within a few months of starting SK
(S. Little, pers. comm.). Recent publications document
false negative antigen tests occur in both dogs and
cats, presumably due to formation of immune com-
plexes, a phenomenon described in the literature
through the 1980s [19,20]. Here we report initial data
indicating false negative antigen tests are common in
dogs on SK.Methods
Source of samples
Serum and EDTA-anticoagulated whole blood samples
were requested from canine patients seen by general prac-
titioners that had been previously diagnosed by the par-
ticipating veterinary practice as infected with D. immitis
by a commercial in-clinic antigen test, with or without
confirmation by microfilaria testing, within the previous
36 months. Specifically, samples were requested from dogs
that had not been treated with the label-approved adulti-
cide (melarsomine dihydrochloride), but instead were
placed on a monthly macrocyclic lactone-based preventive
and doxycycline (SK). A history was collected for each dog
and included patient identification information, previous
heartworm testing method(s), test timing, test result(s),
SK protocol employed, heartworm preventive used, and
compliance with heartworm prevention. Compliance with
heartworm prevention was evaluated based on date of
purchase of heartworm preventive from the clinic. The re-
search protocol was approved by the Novartis Animal
Welfare Officer prior to instituting the research and con-
formed to all requirements and ethical guidelines of both
Novartis Animal Health and Oklahoma State University’s
Center for Veterinary Health Sciences.
Inclusion and exclusion criteria
Samples included in this study were collected from dogs
with a diagnosis of heartworm infection in the past
36 months based on commercial antigen test and that
had converted to antigen-negative status within the past
24 months using any commercially approved in-clinic
antigen test conducted following the manufacturer’s in-
structions. Serum samples were tested upon receipt to
confirm antigen-negative status (see below); only sam-
ples confirmed negative upon receipt were included in
the study. Samples from dogs treated with melarsomine
dihydrochloride and those that could not be confirmed
through the medical records to meet the inclusion re-
quirements were excluded from the study. Serum sam-
ples (3–7 mL) were required from each dog enrolled in
the study. When available, EDTA-anticoagulated whole
blood was also evaluated for microfilariae (see below)
but submission of a paired whole blood sample was not
required for inclusion.
Antigen testing
Upon receipt of each serum sample, antigen negative
status was confirmed on a microtiter well based assay
(DiroCHEK®, Zoetis) according to manufacturer’s in-
structions. Only samples that tested negative upon initial
evaluation were included in the study. Following con-
firmation testing, each sample was heat treated and
retested as previously described [21]. Briefly, 1 mL of
serum was placed in a 1.5 mL snap-cap microcentrifuge
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tory dry heat block, and the resulting coagulum centri-
fuged at 16,000 × g for 5 minutes. After centrifugation,
the supernatant was removed from the coagulum and
tested in triplicate using a microtiter well based assay
(DiroCHEK®, Zoetis) according to manufacturer’s in-
structions. In addition to colorimetric change, spectro-
photometry (650 nm) was used to record the optical
density (O.D.) of each individual sample, before and
after heat treatment, on the same microtiter plate
using the same positive and negative controls and
identical calculated cut-off values [21].
Microfilaria testing
Modified Knott tests were performed on all dogs for which
whole blood samples were available as previously described
[22]. Briefly, 9 mL of 2% formalin was added to 1 mL of
whole blood, the cells allowed to lyse, the mixture centri-
fuged at 1,200 × g, and the pellet stained with methylene
blue and examined by microscopy for microfilariae. Iden-
tify of microfilariae were confirmed by morphology and by
PCR and sequencing as previously described [22,23].
Results
A total of 15 dogs met the enrollment inclusion and ex-
clusion criteria. Serum samples were submitted from allTable 1 Prescribed preventive, administration route, complia









1 Moxidectin Topical No 30d
2 Moxidectin Topical Yes 30d, four times
3 Moxidectin Topical No 30d, four times
4 Ivermectin Oral Yes 30d, twice
5 Ivermectin Oral No 30d
6 Ivermectin Oral No 30d, twice
7 Ivermectin Oral Yes 30d, twice
8 Ivermectin Oral No 30d
9 Moxidectin Topical Yes 6mo
10 Moxidectin Topical No 30d, twice
11 Ivermectin Oral Yes 30d
12 Ivermectin Oral Yes 30d, twice
13 Ivermectin Oral No 30d
14 Ivermectin, Oral Yes 30d, twice
Milbemycin Oral
15 Ivermectin, Oral No 30d, three times
Milbemycin Oral
*Identity of microfilariae confirmed as Dirofilaria immitis by morphology and by PCR
ND = Not Done.15 dogs. Antigen testing of the samples post-heating re-
vealed serum from 8 of 15 dogs (53.3%) that had become
antigen negative following SK therapy were actually still
antigen positive; samples from 7 of 15 (46.7%) dogs
remained antigen negative after heating (Table 1). Paired
anticoagulated whole blood samples were submitted from 9
of 15 dogs; of these, 1/9 (11.1%) had evidence of microfilar-
iae. Microfilariae were confirmed as D. immitis via morph-
ology and PCR followed by sequencing (data not shown).
Evaluation of medical records from each dog revealed
SK was performed using monthly low-dose ivermectin
(HeartGard Plus®, Merial or IverHeart Plus®, Virbac) in
10 dogs and monthly topical moxidectin/imidicloprid
(AdvantageMulti for Dogs®, Bayer Animal Health) in 5
dogs (Table 1). Two of the 10 dogs initially prescribed
low-dose ivermectin were switched to a monthly pre-
ventive containing milbemycin oxime (Trifexis®, Elanco
or Sentinel® Flavor Tabs, Novartis Animal Health) fol-
lowing conversion to negative heartworm antigen status.
All 15 dogs were prescribed doxycycline at some point
for various periods of time; one dog received 6 months
of doxycycline, while all other dogs were prescribed sin-
gle or multiple, intermittent 30d courses of therapy
(Table 1). Based on purchase history, 7 of the 15 dogs
had evidence in the medical records supporting compli-
ance with monthly preventive as prescribed.nce, doxycycline use, and results of modified Knott test
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Together, these data indicate that antigen tests may
not be a reliable indicator of heartworm antigen status
in D. immitis-infected dogs managed with SK; over half
the dogs which converted to antigen negative were ac-
tually still antigen positive following treatment of serum
to disrupt immune complexes. Experimental infection
studies have shown that SK prolongs the death of adult
worms over 16 months to more than 3 years depending
on the age of the worms when the protocol is first initi-
ated [11,12]. During SK, inflammation is induced which is
radiographically evident and can exacerbate clinical dis-
ease [4,24]. We suspect that the hypergammaglobulinemic
state induced by the reaction to dead and dying worms
allows formation of antigen-antibody complexes in
some canine patients, masking antigen of D. immitis
and preventing detection on subsequent assays. A sim-
ple heat treatment step prior to antigen assay of serum
would be expected to destroy any complexes, if present,
and allow detection of antigen, the reason this step was
routinely included when heartworm antigen tests were
first developed [25,26].
A limitation of the present study is that the dogs stud-
ied were pet dogs and therefore no necropsy data or
worm counts were available. Although over half the dogs
testing negative were actually shown to harbor antigen,
we may have been detecting residual antigen in some
dogs without the concomitant presence of live, adult
worms. Similarly, because a second, microtiter well
based confirmatory antigen test was not documented for
all dogs prior to starting SK, some dogs which appar-
ently converted to true negative may not have been ori-
ginally infected. Nonetheless, the results of the present
study draw attention to the possibility that false negative
antigen test results may commonly develop in dogs on
SK, a problem which could mislead veterinarians in clin-
ical practice about the infection status of their patients.
One of the dogs in the present study managed with a
SK protocol and initially antigen negative had circulating
microfilariae (Table 1), while microfilariae were not de-
tected in the other 8 dogs for which whole blood was
available; the microfilaria status of the 6 dogs for which
only serum was provided is unknown. These data sup-
port previous findings suggesting microfilariae continue
to be present in some dogs despite monthly administra-
tion of macrocyclic lactones [15]. Although not repro-
duced experimentally, one potentially catastrophic effect
of the use of SK is increased selection for resistance to
the macrocyclic lactones, the anthelmintic class of all
currently available heartworm preventives [15]. This
phenomenon was recently investigated by administering
repeated doses of ivermectin to a dog infected with
macrocyclic lactone-resistant Dirofilaria immitis, result-
ing in an apparent shift in the proportion of microfilariaewith resistant markers, a result interpreted to be consist-
ent with the effect of increased selective pressure [27].
Some dispute the importance of the resistance concern by
citing research showing that third-stage larvae produced
from microfilariae harvested from dogs treated with doxy-
cycline are unable to develop to adult worms [28,29].
While important, those experiments have involved a small
number of dogs (n = 1 or 2) challenged with a small num-
ber of larvae (n = 5 – 50). Extending the findings to a large
population of infected dogs in the field may be imprudent,
particularly given the growing awareness of resistance to
macrocyclic lactones in D. immitis in North America.
Interestingly, the present study also documented that
compliance with SK was poor despite a heartworm diag-
nosis and owner awareness of an active heartworm in-
fection. These data confirm what many veterinarians
have long suspected: successfully implementing SK in
practice is challenging because it requires a long-term
commitment from the pet owner to complete the proto-
col. Based on review of purchase records alone, over half
of the dogs in this study did not complete the SK proto-
col as prescribed (Table 1). Because the preventive used
in SK is intended to protect against future D. immitis in-
fection as well as clear existing nematodes15, some of
the dog in the present study also may have been re-
infected due to poor or non-compliance; this reinfec-
tion and subsequent development of adult heart-
worms may have contributed to the presence of
blocked antigen in some patients which was revealed
only upon heat treatment of serum. Nonetheless, several
dogs being managed with SK tested false negative on
standard commercial antigen tests, indicating that many
negative antigen test results from dogs on SK may not be
accurate.Conclusions
Managing D. immitis-infected dogs with monthly macro-
cyclic lactones and doxycycline can create false negative
results on heartworm antigen tests, misleading veterinar-
ians and pet owners about the efficacy of this approach.
The data from the present study indicate that antigen de-
tection as a primary outcome measure is not an accurate
means of determining SK success, suggesting previously
reported efficacy of SK in pet dogs in clinical practice
should be reconsidered. Adulticide therapy with melarso-
mine dihydrochloride remains the treatment recom-
mended by the Companion Animal Parasite Council, the
European Scientific Counsel Companion Animal Para-
sites, and the American Heartworm Society for dogs in-
fected with adult heartworms.
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